Real life outcomes matter

Breaking DEM-TACE news from ESMO GI

Join this online webcast covering more than 550 patients data from EMSO GI. We aim to give DEM-TACE a stronger voice in tumour board discussions by sharing real world data and the latest news on LifePearlTM microspheres.

Educational objectives

• Share the latest news from ESMO-GI about real world clinical outcomes of >550 HCC patients treated with DEM-TACE
• Discuss the impact of big data from liver directed therapies to the multidisciplinary tumour board decision making process
• Explore DEM-TACE current practice and performance in various subsets of patients